AERIE PHARMACEUTICALS (AERI) Covered Calls

AERIE PHARMACEUTICALS covered calls Aerie Pharmaceuticals Inc is a clinical-stage pharmaceutical company engaged in the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye.

You can sell covered calls on AERIE PHARMACEUTICALS to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for AERI (prices last updated Wed 4:16 PM ET):

AERIE PHARMACEUTICALS (AERI) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
56.20 -0.35 55.10 56.80 317K - 2.6B
Covered Calls For AERIE PHARMACEUTICALS (AERI)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Sep 21 55 1.20 55.60 -1.1% -133.8%
Oct 19 55 2.95 53.85 2.1% 24.7%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Aerie Pharmaceuticals, Inc. is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. The company's product candidates are tiple action Rhopressa and quadruple action Roclatan. Aerie Pharmaceuticals was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem and Eric J. Toone on June 22, 2005 and is headquartered in Irvine, CA.